CureMeAbroad: Making Global Healthcare More Accessible Through AI

Problem

Patients exploring overseas treatment often face fragmented information, uncertain hospital credentials, unclear pricing and complicated travel arrangements. Language barriers and the absence of reliable coordination can further complicate the process. CureMeAbroad aims to address these challenges through verified healthcare discovery, treatment comparisons and end-to-end patient assistance.

Product

CureMeAbroad offers a digital platform to discover and compare international hospitals, doctors and medical procedures. Its services include treatment estimates, hospital introductions, AI-powered cost estimation, journey planning, teleconsultation coordination and travel assistance. The platform covers specialties including fertility, bariatric surgery, cardiac care, orthopaedics, dentistry and cosmetic procedures.

Proof

CureMeAbroad's official website lists a network of more than 1,500 hospitals and 3,600 doctors across 38-plus countries. In its October 2026 company update, it reported more than 400 hospital partners across Turkey, Thailand, India, Mexico and Georgia, alongside a 4.8-times revenue increase across Q1 and Q2 and operational profitability. The company also reported a $4.8 million annual booking run rate.

People

CureMeAbroad was co-founded by Aditya Oza, CEO, and Mikhail Bohra, CMO. Oza previously co-founded electric mobility company EMotorad, while Bohra co-founded Harbor365. Their combined experience in entrepreneurship, technology and business development is shaping the company's international healthcare expansion strategy.

Purse

In October 2026, CureMeAbroad announced a $1.1 million pre-seed funding round, led by healthcare-focused venture capital fund SteerX Ventures, with participation from existing investor AIRA. The company plans to deploy the capital towards expanding its hospital network, entering new international patient markets, strengthening its AI platform and growing its technology and operations teams.

Plan

CureMeAbroad is expanding its physical presence beyond India, with experience centres planned across Australia, the US and the UK. It is also broadening its treatment portfolio into oncology, neurology, orthopaedics, IVF and surrogacy, while exploring new destination markets such as Mexico, Vietnam and Indonesia. The company has set a target of $100 million in annual patient treatment bookings by FY2028.

Why it matters:

CureMeAbroad is addressing the trust and coordination challenges associated with international healthcare access. By bringing hospital discovery, treatment estimates, patient assistance and travel coordination onto one platform, it is working to make medical tourism more transparent and organised while strengthening India's position as a global healthcare destination.

Disclaimer: This profile is based on publicly available company information, official website disclosures and company announcements reviewed as of 6 November 2026.